OptimizeRx (OPRX) Total Liabilities (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Total Liabilities data on file, last reported at $37.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 26.88% year-over-year to $37.7 million; the trailing twelve-month figure through Mar 2026 stood at $37.7 million (down 26.88% YoY), and the FY2025 full-year result was $48.6 million, down 10.24% from the prior year.
• Total Liabilities slipped to $37.7 million in Q1 2026, from $48.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $56.8 million in Q4 2023 to a low of $5.5 million in Q2 2023.
• A 5-year average of $32.5 million and a median of $48.1 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 841.25% in 2024 and decreased 26.88% in 2026, its largest moves.
• Tracing OPRX's Total Liabilities over 5 years: stood at $8.5 million in 2022, then jumped by 565.32% to $56.8 million in 2023, then slipped by 4.67% to $54.2 million in 2024, then decreased by 10.24% to $48.6 million in 2025, then declined by 22.56% to $37.7 million in 2026.
• Business Quant data shows OPRX's Total Liabilities at $37.7 million in Q1 2026, $48.6 million in Q4 2025, and $48.1 million in Q3 2025.